← Back to Analyst Consensus 
USPH Buy
U S PHYSICAL THERAPY INC /NV
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 10, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Jun 24, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 46% |
| May 13, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 8, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Feb 20, 2026 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Jan 5, 2026 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Nov 24, 2025 | JP Morgan | maintain | Overweight → Overweight | $100 | 55% |
| Oct 24, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Aug 8, 2025 | Barrington Research | maintain | Outperform → Outperform | $103 | 56% |
| Jul 1, 2025 | Barrington Research | maintain | Outperform → Outperform | $98 | 56% |
| Apr 22, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $113 | 53% |
| Mar 19, 2025 | JP Morgan | maintain | Overweight → Overweight | $110 | 55% |
| Feb 28, 2025 | Barrington Research | maintain | Outperform → Outperform | $98 | 56% |
| Dec 16, 2024 | B of A Securities | upgrade | Neutral → Buy | $115 | 53% |
| Dec 16, 2024 | JMP Securities | initiate | — → Market Outperform | $113 | 53% |
| Dec 3, 2024 | JP Morgan | maintain | Overweight → Overweight | $120 | 55% |
| Nov 21, 2024 | Barrington Research | maintain | Outperform → Outperform | $108 | 56% |
| Nov 7, 2024 | Barrington Research | maintain | Outperform → Outperform | $108 | 56% |
| Oct 9, 2024 | Barrington Research | maintain | Outperform → Outperform | $108 | 56% |
| Oct 7, 2024 | B of A Securities | downgrade | Buy → Neutral | $90 | 53% |
| Sep 20, 2024 | Barrington Research | maintain | Outperform → Outperform | $108 | 56% |
| Aug 15, 2024 | Barrington Research | maintain | Outperform → Outperform | $108 | 56% |
| May 9, 2024 | Barrington Research | maintain | Outperform → Outperform | $122 | 56% |
| Mar 13, 2024 | JP Morgan | maintain | Overweight → Overweight | $117 | 55% |
| Mar 1, 2024 | Barrington Research | maintain | Outperform → Outperform | $122 | 56% |
| Jan 3, 2024 | Barrington Research | maintain | Outperform → Outperform | $120 | 56% |
| Nov 17, 2023 | JP Morgan | maintain | Overweight → Overweight | $99 | 55% |
| Nov 9, 2023 | Barrington Research | maintain | Outperform → Outperform | $111 | 56% |
| Sep 22, 2023 | JP Morgan | initiate | — → Overweight | $108 | 55% |
| Sep 19, 2023 | CJS Securities | upgrade | Market Perform → Market Outperform | $0 | 41% |
| Aug 14, 2023 | Barrington Research | maintain | Outperform → Outperform | $124 | 56% |
| Jun 30, 2023 | B of A Securities | initiate | — → Buy | $138 | 53% |
| May 5, 2023 | Barrington Research | maintain | — → Outperform | $116 | 56% |
| Feb 24, 2023 | Barrington Research | maintain | — → Outperform | $110 | 56% |
| Dec 14, 2021 | CJS Securities | upgrade | Market Perform → Market Outperform | $120 | 41% |
| May 7, 2021 | Barrington Research | upgrade | Market Perform → Outperform | $130 | 56% |
| May 3, 2021 | Jefferies | upgrade | Hold → Buy | $135 | 52% |
| Feb 26, 2021 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Mar 27, 2020 | Sidoti & Co. | maintain | — → Buy | $80 | 40% |
| Nov 8, 2019 | Barrington Research | upgrade | Market Perform → Outperform | $130 | 56% |
| Mar 8, 2019 | William Blair | initiate | — → Outperform | $0 | 48% |
| Nov 2, 2018 | Cantor Fitzgerald | maintain | Neutral → Neutral | $107 | 50% |
| May 4, 2018 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Nov 3, 2017 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Jul 25, 2017 | Cantor Fitzgerald | initiate | — → Overweight | $72 | 50% |
| Mar 17, 2017 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Nov 4, 2016 | Barrington Research | upgrade | Market Perform → Outperform | $0 | 56% |
| Aug 5, 2016 | Jefferies | maintain | — → Hold | $65 | 52% |
| May 6, 2016 | Barrington Research | upgrade | Market Perform → Outperform | $0 | 56% |
Price Target Trend
Apr 15, 2026 Latest: $97 Oct 24, 2026
EPS Estimates
0q $0.73
Lo: $0.57 Hi: $0.90
6 analysts ▲1
+1y $3.35
Lo: $2.98 Hi: $3.80
6 analysts ▲1
+1q $0.91
Lo: $0.80 Hi: $1.10
6 analysts ▲1
0y $2.90
Lo: $2.70 Hi: $3.18
5 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days